Intranasal lorazepam

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIntranasal lorazepam
Drug Alias NameNRL-2NRL-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGABA receptors agonists
TargetsNot applicable
Therapy Area/IndicationsAnxiety DisordersStatus Epilepticus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeurelis Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeurelis Inc
Inactive CompaniesN/A
Active IndicationsAnxiety DisordersStatus Epilepticus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A